English

Anthera Pharmaceuticals Inc

EDGAR

Filing (3) · filed 2018-09-12

117 filing records in this dataset, filed from 2009-09-15 to 2018-09-12. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2016 Q4 · USD

Exact inputs and evidence

Revenue: 145000 USD Source
Revenue: 145000 USD Source

Operating cash flow

-12.2 million USD

2016 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -48919000 USD Source
Operating Cash Flow: -36691000 USD Source

Cash and cash equivalents: 8.09 million USD 2018-03-31 Source
Exact value

8086000 USD
Long-term debt including current maturities: 18.1 million USD 2013-12-31 Source
Exact value

18095000 USD
Shares outstanding: 26.2 million shares 2018-03-31 Source
Exact value

26179302 shares

Reported share-count change

159.81% · 16.1 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

10076164 shares · 2017-03-31· Source
26179302 shares · 2018-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

145 thousand USD

2016-01-01 – 2016-12-31

Exact inputs and evidence

Revenue: 145000 USD · 2016-01-01 – 2016-03-31 Source
Revenue: 145000 USD · 2016-01-01 – 2016-06-30 Source
Revenue: 145000 USD · 2016-01-01 – 2016-03-31 Source
Revenue: 145000 USD · 2016-01-01 – 2016-09-30 Source
Revenue: 145000 USD · 2016-01-01 – 2016-06-30 Source
Revenue: 145000 USD · 2016-01-01 – 2016-12-31 Source
Revenue: 145000 USD · 2016-01-01 – 2016-09-30 Source

Net income

-23.4 million USD

2017-04-01 – 2018-03-31

Exact inputs and evidence

Net income: 313000 USD · 2017-04-01 – 2017-06-30 Source
Net income: -6307000 USD · 2017-07-01 – 2017-09-30 Source
Net income: -26874000 USD · 2017-01-01 – 2017-12-31 Source
Net income: -17201000 USD · 2017-01-01 – 2017-09-30 Source
Net income: -7724000 USD · 2018-01-01 – 2018-03-31 Source

Operating cash flow

-32 million USD

2017-04-01 – 2018-03-31

Exact inputs and evidence

Operating cash flow: -24442000 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: -14329000 USD · 2017-01-01 – 2017-03-31 Source
Operating cash flow: -30640000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -24442000 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: -36900000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: -30640000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -9381000 USD · 2018-01-01 – 2018-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-09-12.

Financial data available through: 2016-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2016-12-31
Operating income: 9 of 11 periods available· newest 2016-12-31
Net income: 11 of 11 periods available· newest 2016-12-31
Operating cash flow: 9 of 11 periods available· newest 2016-12-31
Capital expenditure: 8 of 11 periods available· newest 2016-12-31
Total assets: 2 of 11 periods available· newest 2016-12-31
Total liabilities: 2 of 11 periods available· newest 2016-12-31
Current assets: 2 of 11 periods available· newest 2016-12-31
Current liabilities: 2 of 11 periods available· newest 2016-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2016-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-95.4%

Prior period

USD 3.19 million

2015-01-01 – 2015-12-31
Current period

USD 145,000

2016-01-01 – 2016-12-31

Exact inputs and evidence

145000 − 3185000 = -3040000 USD

3185000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
145000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Anthera Pharmaceuticals Inc · 2016-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Year-over-year change in Revenue: -3040000 USD Concept: fundies:Revenue Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 145000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#143833 Filing: 000121465918001789 Input fundies:Revenue: 3185000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#143623 Filing: 000121465918001789
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 20.3 million

Prior period

−USD 35.22 million

2015-01-01 – 2015-12-31
Current period

−USD 55.52 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-55523000 − -35220000 = -20303000 USD

-35220000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-55523000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Anthera Pharmaceuticals Inc · 2016-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Year-over-year change in Net income: -20303000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -55523000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#138393 Filing: 000121465918001789 Input fundies:NetIncome: -35220000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#137006 Filing: 000121465918001789
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 18.01 million

Prior period

−USD 30.91 million

2015-01-01 – 2015-12-31
Current period

−USD 48.92 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-48919000 − -30907000 = -18012000 USD

-30907000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-48919000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Anthera Pharmaceuticals Inc · 2016-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Year-over-year change in Operating cash flow: -18012000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -48919000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#364338 Filing: 000121465918001789 Input fundies:OperatingCashFlow: -30907000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#363965 Filing: 000121465918001789
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+857.5%

Prior period

USD 80,000

2015-01-01 – 2015-12-31
Current period

USD 766,000

2016-01-01 – 2016-12-31

Exact inputs and evidence

766000 − 80000 = 686000 USD

80000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
766000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Anthera Pharmaceuticals Inc · 2016-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Year-over-year change in Capital expenditure: 686000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 766000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#139862 Filing: 000121465918001789 Input fundies:CapitalExpenditure: 80000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#139552 Filing: 000121465918001789
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 145,000 100% of revenue
Operating costs Derived USD 57.32 million 39,532% of revenue
Operating income −USD 57.18 million −39,432% of revenue
Tax, interest and other Derived −USD 1.65 million −1,141% of revenue
Net income −USD 55.52 million −38,292% of revenue

Cash

Operating cash flow −USD 48.92 million −33,737% of revenue
Capital expenditure USD 766,000 528% of revenue
Free cash flow Derived −USD 49.69 million −34,266% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 1,207% of revenue.
2016 Operating loss: operating costs were 39,532% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	3185000	38428000 Derived	-35243000	-23000 Derived	-35220000	-30987000 Derived	Source 2015-01-01 – 2015-12-31: 3185000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -35243000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -35220000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -30907000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 80000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	145000	57322000 Derived	-57177000	-1654000 Derived	-55523000	-49685000 Derived	Source 2016-01-01 – 2016-12-31: 145000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -57177000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -55523000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -48919000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 766000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 145K 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	3185000	Revenue: 3185000 Open source
20162016-12-31	Revenue	145000	Revenue: 145000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-95.4% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 3185000 Open source
20162016-12-31	Year over year	-95.4%	Revenue: 145000 Open source Revenue: 3185000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -39,432.4% 2016

Net margin -38,291.7% 2016

Free cash flow margin -34,265.5% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-1,106.5%	Operating Income: -35243000 Open source Revenue: 3185000 Open source
20162016-12-31	Operating margin	-39,432.4%	Operating Income: -57177000 Open source Revenue: 145000 Open source
20152015-12-31	Net margin	-1,105.8%	Net Income: -35220000 Open source Revenue: 3185000 Open source
20162016-12-31	Net margin	-38,291.7%	Net Income: -55523000 Open source Revenue: 145000 Open source
20152015-12-31	Free cash flow margin	-972.9%	Revenue: 3185000 Open source Operating Cash Flow: -30907000 Open source Capital Expenditure: 80000 Open source
20162016-12-31	Free cash flow margin	-34,265.5%	Revenue: 145000 Open source Operating Cash Flow: -48919000 Open source Capital Expenditure: 766000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -48.9M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-30907000	Operating Cash Flow: -30907000 Open source
20162016-12-31	Operating cash flow	-48919000	Operating Cash Flow: -48919000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -49.7M 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	-30987000	Operating Cash Flow: -30907000 Open source Capital Expenditure: 80000 Open source
20162016-12-31	Free cash flow	-49685000	Operating Cash Flow: -48919000 Open source Capital Expenditure: 766000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

45.3% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	17.6%	Total Liabilities: 8468000 Open source Total Assets: 48125000 Open source
20162016-12-31	Liabilities / assets	45.3%	Total Liabilities: 10624000 Open source Total Assets: 23471000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.14× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	5.65×	Current Assets: 47862000 Open source Current Liabilities: 8468000 Open source
20162016-12-31	Current assets / current liabilities	2.14×	Current Assets: 22708000 Open source Current Liabilities: 10624000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2007-01-01 – 2007-12-31	−USD 25.7 million Exact value Exact value: -25695000 USD 2007-01-01 – 2007-12-31: -25695000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2007-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -25695000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25695000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#929171 Filing: 000121465914002323 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 18.1 million Exact value Exact value: -18099000 USD 2008-01-01 – 2008-12-31: -18099000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2008-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -18099000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18099000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#929356 Filing: 000121465914002323 The citation records this snapshot. The page link may show a newer release later.	−USD 17.12 million Exact value Exact value: -17124797 USD 2008-01-01 – 2008-12-31: -17124797 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2008-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -17124797 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17124797 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/0000950123-11-022379.txt#53462 The citation records this snapshot. The page link may show a newer release later.	USD 6,752 Exact value Exact value: 6752 USD 2008-01-01 – 2008-12-31: 6752 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anthera Pharmaceuticals Inc · 2008-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Capital Expenditure: 6752 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6752 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/0000950123-11-022379.txt#53625 The citation records this snapshot. The page link may show a newer release later.	−USD 17.13 million Calculation and evidence -17124797 − 6752 USD Exact free cash flow: -17131549 USD 2008-01-01 – 2008-12-31: -17124797 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 6752 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anthera Pharmaceuticals Inc · 2008-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Free cash flow: -17131549 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17124797 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/0000950123-11-022379.txt#53462 Input fundies:CapitalExpenditure: 6752 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/0000950123-11-022379.txt#53625 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 12.2 million Exact value Exact value: -12203000 USD 2009-01-01 – 2009-12-31: -12203000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2009-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -12203000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12203000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#929541 Filing: 000121465914002323 The citation records this snapshot. The page link may show a newer release later.	−USD 17.17 million Exact value Exact value: -17172000 USD 2009-01-01 – 2009-12-31: -17172000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2009-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -17172000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17172000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000104746912002644/anth-20111231.xml#528187 Filing: 000104746912002644 The citation records this snapshot. The page link may show a newer release later.	USD 4,000 Exact value Exact value: 4000 USD 2009-01-01 – 2009-12-31: 4000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anthera Pharmaceuticals Inc · 2009-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Capital Expenditure: 4000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000104746912002644/anth-20111231.xml#519878 Filing: 000104746912002644 The citation records this snapshot. The page link may show a newer release later.	−USD 17.18 million Calculation and evidence -17172000 − 4000 USD Exact free cash flow: -17176000 USD 2009-01-01 – 2009-12-31: -17172000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 4000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anthera Pharmaceuticals Inc · 2009-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Free cash flow: -17176000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17172000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000104746912002644/anth-20111231.xml#528187 Filing: 000104746912002644 Input fundies:CapitalExpenditure: 4000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000104746912002644/anth-20111231.xml#519878 Filing: 000104746912002644 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 46.71 million Exact value Exact value: -46714000 USD 2010-01-01 – 2010-12-31: -46714000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2010-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -46714000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46714000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#928433 Filing: 000121465914002323 The citation records this snapshot. The page link may show a newer release later.	−USD 27.78 million Exact value Exact value: -27778000 USD 2010-01-01 – 2010-12-31: -27778000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2010-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -27778000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27778000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465913001633/anth-20121231.xml#621046 Filing: 000121465913001633 The citation records this snapshot. The page link may show a newer release later.	USD 22,000 Exact value Exact value: 22000 USD 2010-01-01 – 2010-12-31: 22000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anthera Pharmaceuticals Inc · 2010-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Capital Expenditure: 22000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465913001633/anth-20121231.xml#656116 Filing: 000121465913001633 The citation records this snapshot. The page link may show a newer release later.	−USD 27.8 million Calculation and evidence -27778000 − 22000 USD Exact free cash flow: -27800000 USD 2010-01-01 – 2010-12-31: -27778000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 22000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anthera Pharmaceuticals Inc · 2010-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Free cash flow: -27800000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27778000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465913001633/anth-20121231.xml#621046 Filing: 000121465913001633 Input fundies:CapitalExpenditure: 22000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465913001633/anth-20121231.xml#656116 Filing: 000121465913001633 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 99.07 million Exact value Exact value: -99073000 USD 2011-01-01 – 2011-12-31: -99073000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2011-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -99073000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -99073000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#927326 Filing: 000121465914002323 The citation records this snapshot. The page link may show a newer release later.	−USD 73.07 million Exact value Exact value: -73067000 USD 2011-01-01 – 2011-12-31: -73067000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2011-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -73067000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -73067000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#926291 Filing: 000121465914002323 The citation records this snapshot. The page link may show a newer release later.	USD 1.35 million Exact value Exact value: 1346000 USD 2011-01-01 – 2011-12-31: 1346000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anthera Pharmaceuticals Inc · 2011-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Capital Expenditure: 1346000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1346000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#990431 Filing: 000121465914002323 The citation records this snapshot. The page link may show a newer release later.	−USD 74.41 million Calculation and evidence -73067000 − 1346000 USD Exact free cash flow: -74413000 USD 2011-01-01 – 2011-12-31: -73067000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 1346000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anthera Pharmaceuticals Inc · 2011-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Free cash flow: -74413000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -73067000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#926291 Filing: 000121465914002323 Input fundies:CapitalExpenditure: 1346000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465914002323/anth-20131231.xml#990431 Filing: 000121465914002323 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 45.33 million Exact value Exact value: -45329000 USD 2012-01-01 – 2012-12-31: -45329000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2012-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -45329000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45329000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465915002302/anth-20141231.xml#2010557 Filing: 000121465915002302 The citation records this snapshot. The page link may show a newer release later.	−USD 73.64 million Exact value Exact value: -73635000 USD 2012-01-01 – 2012-12-31: -73635000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2012-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -73635000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -73635000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465915002302/anth-20141231.xml#2016040 Filing: 000121465915002302 The citation records this snapshot. The page link may show a newer release later.	USD 207,000 Exact value Exact value: 207000 USD 2012-01-01 – 2012-12-31: 207000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anthera Pharmaceuticals Inc · 2012-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Capital Expenditure: 207000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 207000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465915002302/anth-20141231.xml#2016551 Filing: 000121465915002302 The citation records this snapshot. The page link may show a newer release later.	−USD 73.84 million Calculation and evidence -73635000 − 207000 USD Exact free cash flow: -73842000 USD 2012-01-01 – 2012-12-31: -73635000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 207000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anthera Pharmaceuticals Inc · 2012-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Free cash flow: -73842000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -73635000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465915002302/anth-20141231.xml#2016040 Filing: 000121465915002302 Input fundies:CapitalExpenditure: 207000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465915002302/anth-20141231.xml#2016551 Filing: 000121465915002302 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 30.86 million Exact value Exact value: -30861000 USD 2013-01-01 – 2013-12-31: -30861000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2013-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -30861000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30861000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465916010295/anth-20151231.xml#98092 Filing: 000121465916010295 The citation records this snapshot. The page link may show a newer release later.	−USD 31.91 million Exact value Exact value: -31912000 USD 2013-01-01 – 2013-12-31: -31912000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2013-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -31912000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31912000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465916010295/anth-20151231.xml#92494 Filing: 000121465916010295 The citation records this snapshot. The page link may show a newer release later.	USD 15,000 Exact value Exact value: 15000 USD 2013-01-01 – 2013-12-31: 15000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anthera Pharmaceuticals Inc · 2013-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Capital Expenditure: 15000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465916010295/anth-20151231.xml#101992 Filing: 000121465916010295 The citation records this snapshot. The page link may show a newer release later.	−USD 31.93 million Calculation and evidence -31912000 − 15000 USD Exact free cash flow: -31927000 USD 2013-01-01 – 2013-12-31: -31912000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 15000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anthera Pharmaceuticals Inc · 2013-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Free cash flow: -31927000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31912000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465916010295/anth-20151231.xml#92494 Filing: 000121465916010295 Input fundies:CapitalExpenditure: 15000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465916010295/anth-20151231.xml#101992 Filing: 000121465916010295 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 29.6 million Exact value Exact value: -29604000 USD 2014-01-01 – 2014-12-31: -29604000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2014-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -29604000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29604000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465917002018/anth-20161231.xml#130871 Filing: 000121465917002018 The citation records this snapshot. The page link may show a newer release later.	−USD 25.6 million Exact value Exact value: -25601000 USD 2014-01-01 – 2014-12-31: -25601000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2014-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -25601000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25601000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465917002018/anth-20161231.xml#125697 Filing: 000121465917002018 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 35.22 million Exact value Exact value: -35220000 USD 2015-01-01 – 2015-12-31: -35220000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2015-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -35220000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35220000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#137006 Filing: 000121465918001789 The citation records this snapshot. The page link may show a newer release later.	−USD 30.91 million Exact value Exact value: -30907000 USD 2015-01-01 – 2015-12-31: -30907000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2015-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -30907000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30907000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#363965 Filing: 000121465918001789 The citation records this snapshot. The page link may show a newer release later.	USD 80,000 Exact value Exact value: 80000 USD 2015-01-01 – 2015-12-31: 80000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anthera Pharmaceuticals Inc · 2015-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Capital Expenditure: 80000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 80000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#139552 Filing: 000121465918001789 The citation records this snapshot. The page link may show a newer release later.	−USD 30.99 million Calculation and evidence -30907000 − 80000 USD Exact free cash flow: -30987000 USD 2015-01-01 – 2015-12-31: -30907000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 80000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anthera Pharmaceuticals Inc · 2015-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Free cash flow: -30987000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30907000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#363965 Filing: 000121465918001789 Input fundies:CapitalExpenditure: 80000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#139552 Filing: 000121465918001789 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 55.52 million Exact value Exact value: -55523000 USD 2016-01-01 – 2016-12-31: -55523000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Anthera Pharmaceuticals Inc · 2016-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Net Income: -55523000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55523000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#138393 Filing: 000121465918001789 The citation records this snapshot. The page link may show a newer release later.	−USD 48.92 million Exact value Exact value: -48919000 USD 2016-01-01 – 2016-12-31: -48919000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Anthera Pharmaceuticals Inc · 2016-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Operating Cash Flow: -48919000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48919000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#364338 Filing: 000121465918001789 The citation records this snapshot. The page link may show a newer release later.	USD 766,000 Exact value Exact value: 766000 USD 2016-01-01 – 2016-12-31: 766000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Anthera Pharmaceuticals Inc · 2016-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Capital Expenditure: 766000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 766000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#139862 Filing: 000121465918001789 The citation records this snapshot. The page link may show a newer release later.	−USD 49.69 million Calculation and evidence -48919000 − 766000 USD Exact free cash flow: -49685000 USD 2016-01-01 – 2016-12-31: -48919000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 766000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Anthera Pharmaceuticals Inc · 2016-12-31 Anthera Pharmaceuticals Inc (edgar:1316175) Free cash flow: -49685000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:22Z Snapshot: cc1dd90731894fdc370ad737fc6a11178a4c9e48b6967e503fc9d4e0a4c9379f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1316175?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48919000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#364338 Filing: 000121465918001789 Input fundies:CapitalExpenditure: 766000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1316175/000121465918001789/anth-20171231.xml#139862 Filing: 000121465918001789 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

117 filings · 1,767 latest values · 1,767 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001316175, 1316175, edgar:1316175

Also known as Anthera Pharmaceuticals Inc

Anthera Pharmaceuticals Inc

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation